Equine Neuro ICVA Diseases

Botulism

Botulism is a rapidly progressive and often fatal neuromuscular disorder in horses caused by neurotoxins produced by the bacterium Clostridium botulinum. This gram-positive, anaerobic, spore-forming bacterium produces several neurotoxin types (A to G), with type B being the most common cause of botulism in horses in the United States. Type C is also occasionally implicated, while type A cases are rare.

Clostridium botulinum toxins block the release of acetylcholine at the neuromuscular junction, leading to flaccid paralysis. The neurotoxin cleaves SNARE proteins involved in the vesicular release of acetylcholine, resulting in the failure of muscle contraction. The onset of clinical signs depends on the amount of toxin exposure and its route into the horse's system. There are three primary forms of botulism in horses:

1. Forage poisoning: Ingestion of preformed toxin in contaminated feed or water, commonly occurring when forage (hay, silage) is improperly stored, leading to anaerobic conditions favorable to bacterial growth.

2. Wound botulism: Toxin production occurs within an infected wound, often in areas with deep, necrotic tissue that allows an anaerobic environment.

3. Toxicoinfectious botulism (Shaker Foal Syndrome): Seen primarily in foals aged 1–2 months, where spores germinate in the undeveloped gastrointestinal tract, producing toxin. (scroll down for more details.)

Clinical Signs

The hallmark of botulism is progressive, symmetric, flaccid paralysis. The clinical presentation can vary in severity depending on the amount of toxin exposure. Watch this video: Horse with botulism

Key clinical signs include:

• Muscle Weakness: Horses often present with generalized weakness, manifested as difficulty in standing, muscle trembling, a stiff gait, and a tucked-up abdomen.

• Dysphagia: Affected horses struggle to eat or drink due to impaired tongue and swallowing reflexes. This may be observed as feed or water dropping out of the mouth, often called "the grain test" (an inability to consume a small amount of feed within a minute).

• Decreased Tail and Tongue Tone: Notably, loss of tongue strength is a pathognomonic sign of botulism. Horses show weak resistance when the tongue is gently pulled out of the mouth.

• Reduced Eyelid Tone: Horses may exhibit ptosis (droopy eyelids) and have a dull, expressionless facial appearance.

• Colic-like Signs: Some horses may present with mild colic symptoms due to decreased gut motility.

• Recumbency: As the disease progresses, the horse may become recumbent, unable to rise, which is a poor prognostic indicator.

Risk Factors

• Forage Contamination: Poorly stored or improperly fermented hay, haylage, or silage, particularly in anaerobic conditions, increases the risk of toxin production. Contamination with animal carcasses can also introduce botulinum spores.

• Soil: Horses grazing in areas with high soil spore counts, such as regions with alkaline, organic-rich soils, are at an elevated risk.

• Wounds: Horses with deep puncture wounds, especially those with necrotic tissue or those that create an anaerobic environment (e.g., penetrating injuries to the sole of the hoof), are at risk of wound botulism.

• Foal Risk: Young foals are particularly susceptible to toxicoinfectious botulism due to their underdeveloped gut flora.

Diagnostics

Diagnosis of botulism can be challenging and is primarily based on clinical signs and history of exposure. However, several diagnostic methods can aid in confirmation:

• Clinical Examination: The grain test (inability to consume feed within a minute) and loss of tongue tone are crucial diagnostic indicators. Horses demonstrating these signs, along with generalized muscle weakness, should be suspected of botulism.

• Mouse Bioassay: Detection of the toxin in feed, serum, gastric contents, or feces can be confirmed using a mouse bioassay, where the suspected material is injected into mice. This is highly specific but time-consuming and requires special facilities.

• Polymerase Chain Reaction (PCR): Identification of C. botulinum DNA in suspected samples (feed, soil, feces) using PCR can be used, although it does not confirm active toxin production.

• Serum Toxin Tests: Enzyme-linked immunosorbent assay (ELISA) tests may be employed to detect botulinum toxins in blood samples, though their sensitivity can vary.

Treatment

Treatment of botulism in horses focuses on neutralizing the toxin and providing supportive care, as the disease progresses rapidly and can be fatal without intervention.

• Antitoxin Administration: Administering botulinum antitoxin is crucial and should be done as early as possible. It neutralizes circulating toxins but does not reverse the effects of toxin already bound to the neuromuscular junction. Type B equine botulinum antitoxin is commonly used and is available commercially.

• Supportive Care: Intensive supportive care is essential for survival:

  • Fluid therapy: For dehydrated horses and those unable to drink.

  • Nutritional support: Horses may require intravenous nutrition or hand-feeding of soft feeds that they can swallow.

  • Muscle support: Slings may be used to support horses that are too weak to stand but not yet recumbent.

  • Wound Care: For wound botulism, aggressive debridement and antibiotic therapy (metronidazole) may help control infection.

• Mechanical Ventilation: In cases of severe respiratory paralysis, mechanical ventilation may be needed. This level of care is typically provided in specialized veterinary facilities.

Prevention

• Vaccination: Vaccines against C. botulinum type B are available and recommended in areas where botulism is common, particularly for broodmares to protect foals via passive immunity.

• Proper Forage Management: Ensuring haylage and silage are properly fermented and stored in anaerobic conditions can help prevent forage poisoning.

• Wound Management: Prompt and appropriate treatment of wounds to avoid anaerobic infection is crucial in reducing the risk of wound botulism.

• Environmental Management: Reducing exposure to soil rich in C. botulinum spores can lower the risk for grazing horses.

Hallmark Clinical Signs and Diagnosis

The most pathognomonic clinical sign of botulism in horses is the rapid development of flaccid paralysis, accompanied by a loss of tongue and eyelid tone. Diagnosis primarily hinges on clinical presentation and history of exposure to risk factors (e.g., suspect feed sources, wound infections). The grain test can aid in field diagnosis, while definitive confirmation may involve laboratory detection of the toxin in biological samples.

By understanding the intricate pathophysiology, risk factors, and clinical signs, veterinarians can swiftly diagnose and manage this often fatal condition in horses.

Shaker Foal Syndrome Explained

Shaker Foal Syndrome is a form of botulism that primarily affects foals between 1 to 2 months of age. It is caused by the ingestion of Clostridium botulinum spores, which germinate and produce neurotoxin within the gastrointestinal tract, making it a type of toxicoinfectious botulism. This condition occurs due to the underdeveloped gut flora in foals, which allows C. botulinum spores to thrive and release neurotoxin.

Pathophysiology

The neurotoxin produced by Clostridium botulinum blocks the release of acetylcholine at neuromuscular junctions by cleaving SNARE proteins, inhibiting vesicular release. This results in flaccid paralysis as muscles fail to contract. The onset of clinical signs can vary based on the toxin load and the foal's age and health status.

Clinical Signs

The hallmark clinical sign is progressive muscle weakness, which manifests as generalized trembling and difficulty standing—hence the term "Shaker Foal." Early signs may include weakness when attempting to stand or walk, muscle fasciculations, and poor muscle tone, especially in the neck and limbs.

Other key signs include:

• Dysphagia: Difficulty in swallowing due to weak tongue and pharyngeal muscles, which may lead to milk regurgitation or aspiration pneumonia.

• Recumbency: As the disease progresses, foals may become recumbent and unable to rise, a poor prognostic sign.

• Decreased eyelid and tail tone: Weak palpebral reflexes and drooping eyelids (ptosis) are often observed, alongside a limp, unresponsive tail.

Diagnosis

Diagnosis is typically based on clinical signs and a history suggestive of exposure to C. botulinum spores. The grain test, though more commonly used in adult horses, can be modified for foals, but its results may not always be conclusive in young animals. Confirmatory diagnostics include detecting botulinum toxin in serum, feces, or gastric contents via mouse bioassay or PCR, though these tests may not always be timely or available.

Treatment

Early intervention is critical for improving survival rates. Key treatment strategies include:

• Antitoxin administration: The equine-derived type B botulinum antitoxin can neutralize circulating toxins but does not reverse the effects of toxin already bound at the neuromuscular junction.

• Supportive care: Intensive supportive care is necessary, often requiring:

  • Fluid therapy to maintain hydration.

  • Nutritional support, sometimes requiring nasogastric feeding or hand feeding.

  • Mechanical ventilation in severe cases where respiratory paralysis occurs.

• Antibiotic therapy: While C. botulinum itself is not the target, secondary infections and pneumonia from dysphagia and aspiration require appropriate antibiotics.

Prognosis

The prognosis for Shaker Foal Syndrome depends heavily on the timing of intervention and the severity of clinical signs at presentation. Early treatment with antitoxin and aggressive supportive care can lead to a favorable outcome, especially in mild cases. However, foals that become recumbent or develop respiratory compromise have a much poorer prognosis.

Prevention

Vaccination of broodmares with the type B botulinum toxoid can confer passive immunity to foals via colostrum. Proper hygiene and feeding practices, such as avoiding contaminated soil and feed, can also reduce the risk of toxicoinfectious botulism in foals.

In summary, Shaker Foal Syndrome is a life-threatening condition that requires prompt diagnosis and treatment to improve survival. Prevention through vaccination and good management practices is the most effective way to reduce its occurrence in young foals.

Cauda equina syndrome

Polyneuritis equi (PNE), also known as cauda equina neuritis, is a rare but progressive and debilitating immune-mediated condition in horses that primarily affects the extradural nerve roots of the cauda equina. The disease leads to chronic inflammation and granulomatous changes in the nerve roots, resulting in progressive lower motor neuron (LMN) dysfunction, particularly of the hindquarters, tail, and bladder. Although PNE most commonly affects the cauda equina, the cranial nerves may also be involved in more advanced cases.

Cauda equina syndrome (CES) and Polyneuritis equi (PNE) are closely related because PNE is a specific cause of cauda equina syndrome in horses. Both conditions involve the cauda equina, the bundle of nerves at the end of the spinal cord responsible for motor and sensory functions in the hindquarters, tail, bladder, and rectum. Cauda equina syndrome (CES), Polyneuritis equi (PNE), and Equine Herpesvirus-1 (EHV-1) are interrelated because both PNE and EHV-1 myeloencephalopathy can lead to CES, and there is potential for EHV-1 to trigger immune-mediated responses, possibly contributing to PNE in some cases.

The exact cause of PNE remains unknown, though it is suspected to have an autoimmune etiology, potentially triggered by prior viral infections or molecular mimicry. This article provides an in-depth examination of the pathophysiology, clinical signs, risk factors, diagnostic approach, and treatment of PNE, with a focus on relevant clinical considerations for veterinary professionals.

Pathophysiology

Polyneuritis equi is primarily characterized by inflammation of the extradural nerve roots, specifically targeting the cauda equina, which consists of the terminal portions of the spinal cord and associated nerve roots responsible for motor and sensory functions in the hindquarters, bladder, rectum, anus, and tail.

The immune-mediated nature of PNE suggests that the body’s immune system erroneously attacks these nerve roots, leading to inflammation and granuloma formation. Over time, chronic inflammation results in the development of fibrosis and scarring, which disrupts normal nerve function. This immune response may be precipitated by:

• Molecular mimicry: Antibodies formed in response to previous infections (e.g., viral) mistakenly recognize antigens on the horse’s nerve tissue.

• Viral associations: There is evidence that viral infections such as Equine Herpesvirus-1 (EHV-1) or other pathogens may act as potential triggers.

The damage to the cauda equina nerve roots leads to the hallmark clinical signs of PNE: progressive weakness, loss of motor control, and sensory deficits in the hindquarters and tail. In more advanced stages, cranial nerves may be affected, manifesting as facial nerve paralysis or other cranial nerve dysfunctions.

Clinical Signs

The clinical signs of polyneuritis equi vary based on the severity and progression of nerve root involvement. In most cases, PNE is a chronic condition that progressively worsens over weeks to months. However, some horses may exhibit acute or subacute onset, particularly if secondary infections or concurrent neurological conditions are present.

Key clinical signs include:

1. Tail weakness and paralysis: The hallmark of PNE, affected horses typically have a flaccid or "limp" tail that cannot be raised or moved voluntarily. The tail is easily lifted by an examiner and lacks resistance.

2. Perineal hypalgesia or anesthesia: Horses with PNE often show diminished or absent sensation in the perineal region, including the anus, vulva, and scrotum. Pinprick tests often elicit reduced or absent responses.

3. Urinary and fecal incontinence: As the nerves controlling bladder and rectal function are affected, horses may dribble urine or have difficulty completely voiding. Fecal incontinence may lead to soiling around the anus, and rectal examination may reveal impaction or an overdistended bladder.

4. Weakness and ataxia of the hind limbs: Horses may exhibit mild to moderate ataxia and proprioceptive deficits in the hind limbs, which can be mistaken for other spinal cord injuries. As the condition progresses, muscle atrophy of the gluteal and pelvic muscles is often observed.

5. Rectal prolapse: In chronic or advanced cases, rectal prolapse may occur due to weakening of the anal sphincter and loss of rectal tone.

6. Cranial nerve involvement: In late-stage disease, cranial nerves may be affected, leading to signs such as facial nerve paralysis, decreased tongue tone, and dysphagia.

The slow, insidious onset and progression of these clinical signs often complicate early diagnosis, as the signs may be subtle or mistaken for other causes of hindlimb weakness or ataxia.

Risk Factors

While the precise cause of PNE remains unclear, several factors may increase the risk of developing the condition:

1. Previous viral infection: Some horses with PNE have a history of viral infections, particularly those caused by Equine Herpesvirus-1 (EHV-1). The immune response to these infections may trigger the immune-mediated attack on the cauda equina nerve roots.

2. Immune dysregulation: Horses with a genetic predisposition to immune-mediated diseases may be more susceptible to developing PNE, particularly if exposed to triggering environmental or infectious agents.

3. Age and breed: Middle-aged to older horses may be more predisposed to PNE, and there is no clear breed predilection, though larger breeds could be more susceptible to cauda equina compression due to their size.

4. Environmental factors: Horses with recurrent exposure to infections or stressors that affect immune function may be at higher risk for immune-mediated disorders like PNE.

Diagnostics

Diagnosing polyneuritis equi can be challenging due to the non-specific nature of early clinical signs and the rarity of the condition. A thorough clinical examination combined with diagnostic tests is essential for accurate diagnosis.

1. Clinical examination: A detailed neurological examination focusing on tail tone, anal tone, and perineal sensation is crucial. Horses with PNE typically have a flaccid tail, weak anal tone, and reduced sensation in the perineal region. Muscle atrophy in the gluteal region and hind limb weakness may also be noted.

2. Cerebrospinal fluid (CSF) analysis: CSF collection via lumbosacral puncture is a key diagnostic tool. Horses with PNE often have elevated protein concentration and mononuclear pleocytosis, indicative of inflammation. Xanthochromia (yellow discoloration) may also be observed in chronic cases due to nerve root damage.

3. Diagnostic imaging:

   • Radiographs: While radiographs of the lumbosacral region may help rule out traumatic or degenerative causes, they are often not diagnostic for PNE.

   • Ultrasonography: May be useful for identifying nerve root abnormalities or granulomas.

   • Advanced imaging: MRI or CT can provide detailed imaging of the cauda equina and reveal any masses or structural abnormalities, though these modalities are not widely available in field practice.

4. Electromyography (EMG): EMG can be helpful in evaluating nerve function and determining the extent of nerve damage. In PNE, EMG may show evidence of denervation or reduced nerve conduction velocity.

5. Serologic testing: Serologic tests to detect viral antibodies (such as for EHV-1) or other infectious agents may be useful in identifying potential triggers of the immune response.

Treatment

The treatment of polyneuritis equi focuses on controlling the immune-mediated inflammation, managing clinical signs, and providing supportive care. However, it is important to note that PNE is a progressive disease, and even with treatment, long-term prognosis is often guarded.

1. Anti-inflammatory therapy:

   • Corticosteroids: Corticosteroids (such as prednisolone or dexamethasone) are the mainstay of treatment, as they help reduce immune-mediated inflammation. High doses are often required initially, followed by gradual tapering.

   • Nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs may be used as adjunctive therapy to manage inflammation and pain, though they are less effective in controlling immune-mediated damage compared to corticosteroids.

2. Immunosuppressive therapy: In cases refractory to corticosteroids, immunosuppressive agents such as azathioprine or cyclosporine may be considered to further suppress the immune system.

3. Supportive care:

   • Bladder management: Horses with urinary incontinence may require frequent catheterization to prevent urinary tract infections and bladder overdistension.

   • Nutritional support: In advanced cases where dysphagia is present, nutritional support via hand-feeding or nasogastric feeding may be necessary.

   • Physical therapy: Muscle atrophy and weakness may be managed with physical therapy to maintain muscle tone and joint mobility.

4. Antimicrobial therapy: Although PNE is not infectious, horses with bladder incontinence or dysphagia may be predisposed to secondary infections such as pneumonia or cystitis, which may require appropriate antibiotic therapy.

Prognosis

The prognosis for polyneuritis equi is generally guarded to poor. While corticosteroid therapy can slow the progression of the disease and provide temporary relief, most horses with PNE continue to deteriorate over time. Horses with severe bladder dysfunction, fecal incontinence, or cranial nerve involvement tend to have the worst prognosis, and euthanasia may be necessary in advanced cases.

Hallmark Clinical Signs and Diagnosis

The hallmark clinical signs of PNE include a flaccid tail, urinary and fecal incontinence, and perineal sensory deficits. Diagnosis is based on these clinical signs, combined with CSF analysis revealing elevated protein and mononuclear pleocytosis, and advanced imaging or EMG when available.

Central nervous system trauma

Central nervous system (CNS) trauma in horses is a critical and often life-threatening condition that requires prompt recognition and intervention. The CNS, comprising the brain and spinal cord, can be affected by various forms of trauma, including blunt force injuries, fractures, penetrating wounds, or compressive lesions. Understanding the pathophysiology, clinical presentation, diagnostic approaches, and therapeutic interventions is essential for effective management.

Pathophysiology:

CNS trauma in horses typically involves mechanical injury to neural tissues, resulting in primary and secondary injury processes.

• Primary Injury: This is the direct result of trauma and includes concussion, contusion, laceration, compression, or hemorrhage of CNS tissues. These events cause immediate disruption of neurons, glial cells, and the blood-brain barrier. In cases of spinal trauma, vertebral fractures, luxations, or disc herniations can lead to direct compression of the spinal cord.

• Secondary Injury: Following the primary injury, secondary damage develops over hours to days due to a cascade of biochemical and inflammatory responses. Key components include:

  • Excitotoxicity: Excessive glutamate release leads to overactivation of NMDA receptors, resulting in neuronal death.

  • Oxidative Stress: Production of reactive oxygen species (ROS) damages cellular membranes and organelles.

  • Inflammatory Response: Cytokine release (e.g., IL-1, TNF-α) induces further tissue damage and edema.

  • Vasogenic Edema: Breakdown of the blood-brain or blood-spinal cord barrier leads to fluid leakage and increased intracranial or intraspinal pressure.

  • Ischemia: Compression of blood vessels reduces blood flow to CNS tissues, exacerbating hypoxic injury.

Clinical Signs:

The clinical presentation depends on the location and severity of CNS trauma. Signs can range from subtle to severe and are often acute in onset:

• Brain Trauma:

  • Altered Mental Status: Changes in mentation, including depression, stupor, or coma.

  • Cranial Nerve Deficits: Manifestations such as anisocoria (unequal pupil size), strabismus, facial paralysis, nystagmus, or blindness.

  • Seizures: Generalized or focal seizures may occur due to cortical involvement.

  • Ataxia and Abnormal Gait: Motor deficits may present as stumbling, circling, or ataxia.

  • Head Trauma Specific Signs: Epistaxis, external signs of head injury (e.g., lacerations, hematomas), and vestibular dysfunction (head tilt, loss of balance).

• Spinal Cord Trauma:

  • Ataxia and Weakness: Spinal cord injury typically results in ataxia, paresis, or paralysis. Severity depends on the extent and location of the lesion (e.g., cervical versus thoracolumbar).

  • Proprioceptive Deficits: Lack of limb placement responses.

  • Muscle Atrophy: Chronic injury can lead to muscle wasting in the affected regions.

  • Abnormal Reflexes: Hyperreflexia, hyporeflexia, or absence of reflexes in affected limbs.

Risk Factors:

Several factors predispose horses to CNS trauma, including:

• Behavioral Traits: High-energy horses or those prone to panic and flight responses are more likely to sustain traumatic injuries.

• Environmental Hazards: Obstacles such as fences, stalls, trailers, and uneven terrain can contribute to accidental falls or collisions.

• High-Performance Activities: Jumping, racing, and other athletic activities increase the risk of injury due to falls or collisions.

• Pre-existing Conditions: Conditions like osteoarthritis or vertebral malformations (e.g., Wobbler syndrome) can predispose the spine to injury.

Diagnostics:

A comprehensive diagnostic workup is crucial for assessing the extent and nature of CNS trauma.

• Clinical Examination: A thorough neurological exam is the first step to localizing the lesion. This includes evaluating mentation, cranial nerve function, gait, and proprioception. Reflexes and pain perception should be assessed to gauge spinal cord involvement.

• Imaging:

  • Radiography: Useful for detecting fractures or luxations of the skull or vertebrae.

  • Ultrasound: May assist in evaluating soft tissue injuries, hematomas, or abscesses near the CNS.

  • Advanced Imaging (CT/MRI): CT is valuable for assessing bone and intracranial hemorrhage, while MRI provides detailed information about soft tissue, spinal cord, and brain parenchyma. However, the availability and feasibility of these modalities in equine practice can be limited.

• CSF Analysis: Cerebrospinal fluid (CSF) collection via atlanto-occipital or lumbosacral puncture can reveal evidence of CNS trauma. Findings may include elevated protein levels, xanthochromia (yellow discoloration indicating hemorrhage), and increased red blood cell count. Secondary infections may show elevated white blood cell counts and bacteria.

• Bloodwork: Assessing for systemic inflammation (elevated white blood cells, fibrinogen) and markers of secondary organ damage (e.g., liver, kidney) may support a systemic response to CNS trauma.

Treatment:

Therapeutic interventions aim to mitigate secondary injury, stabilize the patient, and promote recovery.

• Initial Stabilization:

  • Immobilization: Minimize movement in cases of suspected spinal trauma. Horses may require assistance standing or a sling.

  • Control Seizures: Administer benzodiazepines (e.g., diazepam) or barbiturates (e.g., phenobarbital) to control seizures.

• Medical Management:

  • Anti-inflammatory Therapy: Corticosteroids (e.g., dexamethasone) or non-steroidal anti-inflammatory drugs (NSAIDs) like flunixin meglumine may reduce inflammation and edema. The use of corticosteroids is controversial due to potential side effects (e.g., laminitis).

  • Osmotic Agents: Mannitol or hypertonic saline can reduce intracranial or intraspinal pressure by promoting osmotic diuresis.

  • Antioxidants: Vitamin E and other antioxidants may reduce oxidative stress.

  • Antibiotics: Indicated if penetrating injuries or open fractures raise the risk of infection.

  • Supportive Care: Intravenous fluids, nutritional support, and nursing care are critical for maintaining hydration, energy balance, and preventing pressure sores in recumbent horses.

• Surgical Intervention: Indicated in cases of fractures, hematomas, or compressive lesions. Procedures may include decompressive laminectomy for spinal cord compression or stabilization of vertebral fractures.

Hallmark Clinical Signs and Diagnosis:

• Head Trauma: Acute onset of neurological deficits, epistaxis, cranial nerve dysfunction, and altered mentation.

• Spinal Trauma: Rapid development of ataxia, paresis, proprioceptive deficits, and reflex abnormalities.

• Diagnostic Hallmarks: Imaging (radiographs, CT, MRI) confirms structural damage; CSF analysis reveals hemorrhage or inflammation in some cases.

Prognosis:

The prognosis depends on the severity and location of the trauma, as well as the horse's response to treatment. Mild to moderate trauma with early intervention may result in partial to full recovery. Severe CNS trauma, especially involving significant brain injury or high spinal cord compression, carries a guarded to poor prognosis.

Conclusion:

Central nervous system trauma in horses is a complex and challenging condition requiring prompt recognition and comprehensive management. Early intervention, tailored to the specific type and location of injury, significantly impacts outcomes. Understanding the pathophysiology, clinical presentation, and appropriate diagnostics is key to optimizing the care and recovery of equine patients with CNS trauma.

Cervical vertebral malformation/Cervical vertebral Stenotic Myelopathy

Cervical vertebral malformation and damage, often referred to as "wobbler syndrome" or cervical vertebral stenotic myelopathy (CVSM), is a neurological disorder in horses characterized by the compression of the spinal cord within the cervical (neck) vertebrae. This condition can lead to significant clinical symptoms, affecting the horse's coordination, balance, and overall performance. The severity of clinical signs varies based on the extent of spinal cord compression, the location of the lesion, and the horse's activity level.

Pathophysiology

The underlying cause of cervical vertebral malformation typically involves a combination of genetic predisposition, developmental abnormalities, and mechanical factors:

1. Developmental Orthopedic Disease (DOD): Horses, particularly young, fast-growing individuals, are prone to cervical vertebral malformations due to disturbances in endochondral ossification. This results in asymmetrical or irregular bone growth, particularly within the cervical vertebrae (usually C3 to C7), leading to instability or malformation.

2. Stenosis: Narrowing (stenosis) of the spinal canal occurs, resulting in varying degrees of spinal cord compression. There are two main types of compression:

   • Dynamic compression: Occurs when the spinal cord compression is influenced by neck position, often observed between C3-C4 and C4-C5 in younger horses.

   • Static compression: A constant compression of the spinal cord irrespective of the horse's neck position, more common in older horses, usually affecting C5-C6 and C6-C7.

3. Degenerative Joint Disease (DJD): Chronic instability between the vertebrae can lead to osteoarthritic changes in the articular processes of the cervical vertebrae, resulting in further narrowing of the spinal canal.

4. Vascular and Neural Injury: Continuous or intermittent spinal cord compression can disrupt blood flow and cause ischemia, leading to neuronal damage, axonal degeneration, and demyelination within the spinal cord's white matter tracts. The proprioceptive pathways are most commonly affected, leading to ataxia and abnormal gait.

Clinical Signs

The hallmark clinical sign of cervical vertebral malformation is ataxia—a lack of coordination characterized by stumbling, crossing of limbs, or dragging of toes. Severity may range from subtle deficits detectable only on neurological examination to profound ataxia. Other clinical signs include:

• Wobbling gait: Horses exhibit a characteristic unsteady, "wobbly" movement, especially in the hind limbs.

• Stumbling or knuckling: Due to proprioceptive deficits.

• Difficulty backing up: Affected horses may struggle to walk backward or turn in tight circles.

• Hypermetria: Exaggerated limb movements while walking.

• Neck pain: In some cases, palpable pain or resistance to neck movement.

• Weakness: Generalized limb weakness, more noticeable in the hind limbs due to the involvement of the upper motor neuron pathways.

Risk Factors

Several factors increase the risk of cervical vertebral malformation in horses:

1. Breed Predisposition: Taller, fast-growing breeds like Thoroughbreds and Warmbloods are more susceptible due to their rapid growth rates and larger stature.

2. Age: Typically presents in horses between 6 months and 3 years of age. However, older horses (5+ years) may exhibit clinical signs due to static compression caused by degenerative changes.

3. Nutrition: Imbalanced nutrition, particularly excessive caloric intake or improper calcium-phosphorus ratios during growth phases, can contribute to developmental orthopedic diseases, predisposing horses to cervical vertebral malformations.

4. Genetics: A hereditary predisposition has been suggested in certain breeds, although specific genetic markers are not well-established.

5. Trauma: Neck trauma can exacerbate underlying malformations or instigate clinical symptoms by inducing inflammation or instability.

Diagnostics

Accurate diagnosis of cervical vertebral malformation requires a combination of clinical evaluation, neurological examination, and advanced imaging techniques:

1. Neurological Examination: Evaluation of ataxia severity using grading scales (e.g., 0-5 scale) provides a baseline for assessment. Key findings include proprioceptive deficits, reduced neck flexibility, abnormal limb placement, and abnormal gait patterns.

2. Radiography: Cervical spine radiographs can identify malformations, stenosis, vertebral instability, and degenerative joint disease. Common radiographic findings include:

   • Narrowing of the vertebral canal.

   • Malalignment of adjacent vertebrae.

   • Enlargement of articular processes.

   • Subluxation between vertebrae.

3. Myelography: A definitive diagnostic tool involving the injection of contrast medium into the spinal canal to outline the spinal cord. Myelography helps identify dynamic or static compression sites, guiding treatment options. Narrowing of the dorsal and/or ventral contrast columns indicates spinal cord impingement.

4. Computed Tomography (CT) and Magnetic Resonance Imaging (MRI): These advanced imaging modalities provide high-resolution visualization of the cervical spinal cord, nerve roots, and intervertebral discs, offering more detail on the nature and extent of compression.

5. Cerebrospinal Fluid (CSF) Analysis: While not definitive for CVSM, CSF analysis can help rule out other differential diagnoses such as infectious or inflammatory myelopathies.

Treatment

Management of cervical vertebral malformation depends on the severity of spinal cord compression and the horse's age and intended use:

1. Conservative Management:

   • Nutritional Management: For young, growing horses, diet modification to slow growth rates and correct mineral imbalances can help stabilize the progression of malformation.

   • Exercise Restriction: Limiting high-impact activities and stall confinement to reduce the risk of exacerbating spinal cord compression.

   • Anti-Inflammatory Medications: Nonsteroidal anti-inflammatory drugs (NSAIDs) to alleviate inflammation and pain associated with DJD and nerve root impingement.

2. Surgical Intervention:

   • Cervical Vertebral Stabilization: Surgical fusion of the affected vertebrae (commonly referred to as "basket surgery") aims to stabilize the vertebral column and prevent further dynamic compression. This procedure involves placing a bone graft or an implant in the intervertebral space to promote fusion.

   • Decompression: In cases where severe static compression is identified, direct decompression of the spinal canal can be attempted. This is less common and more technically challenging than stabilization.

3. Long-term Management: Following surgery or conservative management, ongoing physical therapy and careful monitoring of neurological function are crucial. Horses may require permanent alterations in their exercise regimen.

Prognosis

The prognosis for horses with cervical vertebral malformation depends on the severity of spinal cord compression, the age at diagnosis, and the response to treatment. Horses with mild to moderate ataxia may improve with conservative management or surgical stabilization. However, horses with severe spinal cord damage or those unresponsive to treatment often have a guarded to poor prognosis for return to athletic performance.

Conclusion

Cervical vertebral malformation in horses is a complex disorder that necessitates a thorough diagnostic approach and individualized treatment strategies. Early recognition of clinical signs and risk factors, coupled with appropriate diagnostic imaging, can guide effective management and improve outcomes in affected horses.

Degenerative Myeloencephalopathy

Narcolepsy/Cataplexy

Neonatal maladjustment syndrome

Peripheral Neuropathy

Seizures

Equine Encephalomyelitis

Equine Motor Neuron Disease

Equine Protozoal myeloencephalitis

Vestibular disease

West Nile Viral Encephalomyelitis